The excitement about excitability

Clinical Neurophysiology

Volumn 121, Issue 6, 2010, Pages 805-806

  Krishnan, Arun V ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; EDITORIAL; EXCITABILITY; HUMAN; HYPERPOLARIZATION; MEMBRANE POTENTIAL; MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER; NERVE FUNCTION; NEUROPHYSIOLOGY; PRIORITY JOURNAL;

HUMANS; HYPERKALEMIA; MUSCULAR DISEASES; UREMIA;

EID: 77952420083     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.01.023     Document Type: Editorial

References (29)

1. Burke D. Microneurography, impulse conduction, and paresthesias. Muscle Nerve 16 (1993) 1025-1032
2. Campistol J.M. Uremic myopathy. Kidney Int 62 (2002) 1901-1913
3. Clyne N. Physical working capacity in uremic patients. Scand J Urol Nephrol 30 (1996) 247-252
4. Evans K., Reddan D.N., and Szczech L.A. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. Semin Dial 17 (2004) 22-29
5. Fournier E., Arzel M., Sternberg D., Vicart S., Laforet P., Eymard B., Willer J.C., Tabti N., and Fontaine B. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56 (2004) 650-661
6. Kanai K., Kuwabara S., Misawa S., Tamura N., Ogawara K., Nakata M., Sawai S., Hattori T., and Bostock H. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129 (2006) 953-962
7. Kiernan M.C., Burke D., Andersen K.V., and Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23 (2000) 399-409
8. Kiernan M.C., Guglielmi J.M., Kaji R., Murray N.M., and Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125 (2002) 664-675
9. Kiernan M.C., Isbister G.K., Lin C.S., Burke D., and Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 57 (2005) 339-348
10. Kiernan M.C., Lin C.S., Andersen K.V., Murray N.M., and Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve 24 (2001) 883-892
11. Kiernan M.C., Walters R.J., Andersen K.V., Taube D., Murray N.M., and Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain 125 (2002) 1366-1378
12. Kitano Y., Kuwabara S., Misawa S., Ogawara K., Kanai K., Kikkawa Y., Yagui K., and Hattori T. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 56 (2004) 462-467
13. Krishnan A.V., and Kiernan M.C. Neurological complications of chronic kidney disease. Nat Rev Neurol 5 (2009) 542-551
14. + pump dysfunction in diabetic neuropathy. Brain 131 (2008) 1209-1216
15. Krishnan A.V., Lin C.S., Park S.B., and Kiernan M.C. Assessment of nerve excitability in toxic and metabolic neuropathies. J Peripher Nerv Syst 13 (2008) 7-26
16. Krishnan A.V., Phoon R.K., Pussell B.A., Charlesworth J.A., Bostock H., and Kiernan M.C. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease. Brain 129 (2006) 1585-1592
17. Krishnan A.V., Phoon R.K., Pussell B.A., Charlesworth J.A., and Kiernan M.C. Sensory nerve excitability and neuropathy in end-stage kidney disease. J Neurol Neurosurg Psychiatry 77 (2006) 548-551
18. Kugelberg E. Accommodation in human nerves and its significance for the symptoms in circulatory disturbances and tetany. Acta Physiol Scand 8 (1944) 1-105
19. Lin C.S., Krishnan A.V., Lee M.-J., Zagami A.S., You H.-L., Yang C.-C., Bostock H., and Kiernan M.C. Nerve function and dysfunction in acute intermittent porphyria. Brain 131 (2008) 2510-2519
20. Mak R.H., and DeFronzo R.A. Glucose and insulin metabolism in uremia. Nephron 61 (1992) 377-382
21. Meyer T.W., Hostetter T.H., Meyer T.W., and Hostetter T.H. Uremia. N Engl J Med 357 (2007) 1316-1325
22. Park S.B., Goldstein D., Lin C.S., Krishnan A.V., Friedlander M.L., and Kiernan M.C. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 27 (2009) 1243-1249
23. Penpargkul S., Bhan A.K., and Scheuer J. Studies of subcellular control factors in hearts of uremic rats. J Lab Clin Med 88 (1976) 563-570
24. Platt D., Griggs R., Platt D., and Griggs R. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol 22 (2009) 524-531
25. Rich M.M., Pinter M.J., Rich M.M., and Pinter M.J. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol (Lond) 547 (2003) 555-566
26. Ritchie A.R. The electrical diagnosis of peripheral nerve injury. Brain 67 (1944) 314
27. Scribner B.H., Buri R., Caner J.E., Hegstrom R., and Burnell J.M. The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs 6 (1960) 114-122
28. Z'Graggen W., Aregger F., Farese S., Humm A.M., Baumann C., Uehlinger D.E., et al. Velocity Recovery Cycles of Human Muscle Action Potentials In Chronic Renal Failure. Clin Neurophysiol 121 6 (2010) 874-881
29. Z'Graggen W.J., Bostock H., Z'Graggen W.J., and Bostock H. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia. Muscle Nerve 39 (2009) 616-626